{"id":3412,"date":"2026-07-01T11:49:00","date_gmt":"2026-07-01T11:49:00","guid":{"rendered":"https:\/\/cielcharlotte.com\/adjane-reports-first-clinical-validation-of-its-omv-vaccine-platform-inducing-mucosal-immunity-in-humans\/"},"modified":"2026-07-01T11:49:00","modified_gmt":"2026-07-01T11:49:00","slug":"adjane-reports-first-clinical-validation-of-its-omv-vaccine-platform-inducing-mucosal-immunity-in-humans","status":"publish","type":"post","link":"https:\/\/development.brstdev.com\/cielcharlotte\/adjane-reports-first-clinical-validation-of-its-omv-vaccine-platform-inducing-mucosal-immunity-in-humans\/","title":{"rendered":"AdJane Reports First Clinical Validation of its OMV Vaccine Platform Inducing Mucosal Immunity in Humans"},"content":{"rendered":"<p>Phase I results provide platform-level validation supporting AdJane&#039;s broader development programs in pandemic preparedness, respiratory infectious diseases and antimicrobial resistanceDELFT, Netherlands, July 1, 2026 \/PRNewswire\/ &#8212;\u00a0AdJane, a clinical-stage vaccine platform company developing intranasal and intramuscular vaccines based on\u2026<\/p>\n<p><a href=\"https:\/\/development.brstdev.com\/cielcharlotte\/wp-content\/uploads\/2026\/09\/in-hellonation-home-inspection-expert-luke-anglea-explains-what-inspectors-check-during-a-south-chicagoland-home-inspection-ai.jpglatest-news\/?prn_release=20260701LN96352\">Read the full release \u2192<\/a><\/p>\n<p><em>News provided by PR Newswire.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Phase I results provide platform-level validation supporting AdJane&#8217;s broader development programs in pandemic preparedness, respiratory infectious diseases and antimicrobial resistanceDELFT, Netherlands, July 1, 2026 \/PRNewswire\/ &#8212;\u00a0AdJane, a clinical-stage vaccine platform company developing intranasal and intramuscular vaccines based on\u2026<\/p>\n","protected":false},"author":14,"featured_media":3413,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-3412","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-art-community"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>AdJane Reports First Clinical Validation of its OMV Vaccine Platform Inducing Mucosal Immunity in Humans - Ciel Charlotte<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AdJane Reports First Clinical Validation of its OMV Vaccine Platform Inducing Mucosal Immunity in Humans - Ciel Charlotte\" \/>\n<meta property=\"og:description\" content=\"Phase I results provide platform-level validation supporting AdJane&#039;s broader development programs in pandemic preparedness, respiratory infectious diseases and antimicrobial resistanceDELFT, Netherlands, July 1, 2026 \/PRNewswire\/ --\u00a0AdJane, a clinical-stage vaccine platform company developing intranasal and intramuscular vaccines based on\u2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/development.brstdev.com\/cielcharlotte\/adjane-reports-first-clinical-validation-of-its-omv-vaccine-platform-inducing-mucosal-immunity-in-humans\/\" \/>\n<meta property=\"og:site_name\" content=\"Ciel Charlotte\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-01T11:49:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/development.brstdev.com\/cielcharlotte\/wp-content\/uploads\/2026\/07\/adjane-reports-first-clinical-validation-of-its-omv-vaccine-platform-inducing-mucosal-immunity-in-humans-ai.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Ethan Parker\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ethan Parker\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/adjane-reports-first-clinical-validation-of-its-omv-vaccine-platform-inducing-mucosal-immunity-in-humans\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/adjane-reports-first-clinical-validation-of-its-omv-vaccine-platform-inducing-mucosal-immunity-in-humans\\\/\"},\"author\":{\"name\":\"Ethan Parker\",\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/#\\\/schema\\\/person\\\/4c5e38434c81d2ebb9c5787b29251450\"},\"headline\":\"AdJane Reports First Clinical Validation of its OMV Vaccine Platform Inducing Mucosal Immunity in Humans\",\"datePublished\":\"2026-07-01T11:49:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/adjane-reports-first-clinical-validation-of-its-omv-vaccine-platform-inducing-mucosal-immunity-in-humans\\\/\"},\"wordCount\":62,\"image\":{\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/adjane-reports-first-clinical-validation-of-its-omv-vaccine-platform-inducing-mucosal-immunity-in-humans\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/adjane-reports-first-clinical-validation-of-its-omv-vaccine-platform-inducing-mucosal-immunity-in-humans-ai.png\",\"articleSection\":[\"Art Community\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/adjane-reports-first-clinical-validation-of-its-omv-vaccine-platform-inducing-mucosal-immunity-in-humans\\\/\",\"url\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/adjane-reports-first-clinical-validation-of-its-omv-vaccine-platform-inducing-mucosal-immunity-in-humans\\\/\",\"name\":\"AdJane Reports First Clinical Validation of its OMV Vaccine Platform Inducing Mucosal Immunity in Humans - Ciel Charlotte\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/adjane-reports-first-clinical-validation-of-its-omv-vaccine-platform-inducing-mucosal-immunity-in-humans\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/adjane-reports-first-clinical-validation-of-its-omv-vaccine-platform-inducing-mucosal-immunity-in-humans\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/adjane-reports-first-clinical-validation-of-its-omv-vaccine-platform-inducing-mucosal-immunity-in-humans-ai.png\",\"datePublished\":\"2026-07-01T11:49:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/#\\\/schema\\\/person\\\/4c5e38434c81d2ebb9c5787b29251450\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/adjane-reports-first-clinical-validation-of-its-omv-vaccine-platform-inducing-mucosal-immunity-in-humans\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/adjane-reports-first-clinical-validation-of-its-omv-vaccine-platform-inducing-mucosal-immunity-in-humans\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/adjane-reports-first-clinical-validation-of-its-omv-vaccine-platform-inducing-mucosal-immunity-in-humans\\\/#primaryimage\",\"url\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/adjane-reports-first-clinical-validation-of-its-omv-vaccine-platform-inducing-mucosal-immunity-in-humans-ai.png\",\"contentUrl\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/adjane-reports-first-clinical-validation-of-its-omv-vaccine-platform-inducing-mucosal-immunity-in-humans-ai.png\",\"width\":1536,\"height\":1024,\"caption\":\"AdJane Reports First Clinical Validation of its OMV Vaccine Platform Inducing Mucosal Immunity in Humans\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/adjane-reports-first-clinical-validation-of-its-omv-vaccine-platform-inducing-mucosal-immunity-in-humans\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AdJane Reports First Clinical Validation of its OMV Vaccine Platform Inducing Mucosal Immunity in Humans\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/#website\",\"url\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/\",\"name\":\"Ciel Charlotte\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/#\\\/schema\\\/person\\\/4c5e38434c81d2ebb9c5787b29251450\",\"name\":\"Ethan Parker\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/ethan-parkar-96x96.jpeg\",\"url\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/ethan-parkar-96x96.jpeg\",\"contentUrl\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/ethan-parkar-96x96.jpeg\",\"caption\":\"Ethan Parker\"},\"description\":\"Ethan Parker covers stories about community life, personal well-being, local initiatives, lifestyle trends, and the people working to create stronger communities. His writing looks for the human element behind larger developments, focusing on practical ideas and meaningful stories. Ethan brings an approachable perspective to subjects involving everyday life, community participation, creativity, and social connection.\",\"url\":\"https:\\\/\\\/development.brstdev.com\\\/cielcharlotte\\\/author\\\/ethan-parker\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AdJane Reports First Clinical Validation of its OMV Vaccine Platform Inducing Mucosal Immunity in Humans - Ciel Charlotte","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"AdJane Reports First Clinical Validation of its OMV Vaccine Platform Inducing Mucosal Immunity in Humans - Ciel Charlotte","og_description":"Phase I results provide platform-level validation supporting AdJane's broader development programs in pandemic preparedness, respiratory infectious diseases and antimicrobial resistanceDELFT, Netherlands, July 1, 2026 \/PRNewswire\/ --\u00a0AdJane, a clinical-stage vaccine platform company developing intranasal and intramuscular vaccines based on\u2026","og_url":"https:\/\/development.brstdev.com\/cielcharlotte\/adjane-reports-first-clinical-validation-of-its-omv-vaccine-platform-inducing-mucosal-immunity-in-humans\/","og_site_name":"Ciel Charlotte","article_published_time":"2026-07-01T11:49:00+00:00","og_image":[{"width":1536,"height":1024,"url":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-content\/uploads\/2026\/07\/adjane-reports-first-clinical-validation-of-its-omv-vaccine-platform-inducing-mucosal-immunity-in-humans-ai.png","type":"image\/png"}],"author":"Ethan Parker","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ethan Parker"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/development.brstdev.com\/cielcharlotte\/adjane-reports-first-clinical-validation-of-its-omv-vaccine-platform-inducing-mucosal-immunity-in-humans\/#article","isPartOf":{"@id":"https:\/\/development.brstdev.com\/cielcharlotte\/adjane-reports-first-clinical-validation-of-its-omv-vaccine-platform-inducing-mucosal-immunity-in-humans\/"},"author":{"name":"Ethan Parker","@id":"https:\/\/development.brstdev.com\/cielcharlotte\/#\/schema\/person\/4c5e38434c81d2ebb9c5787b29251450"},"headline":"AdJane Reports First Clinical Validation of its OMV Vaccine Platform Inducing Mucosal Immunity in Humans","datePublished":"2026-07-01T11:49:00+00:00","mainEntityOfPage":{"@id":"https:\/\/development.brstdev.com\/cielcharlotte\/adjane-reports-first-clinical-validation-of-its-omv-vaccine-platform-inducing-mucosal-immunity-in-humans\/"},"wordCount":62,"image":{"@id":"https:\/\/development.brstdev.com\/cielcharlotte\/adjane-reports-first-clinical-validation-of-its-omv-vaccine-platform-inducing-mucosal-immunity-in-humans\/#primaryimage"},"thumbnailUrl":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-content\/uploads\/2026\/07\/adjane-reports-first-clinical-validation-of-its-omv-vaccine-platform-inducing-mucosal-immunity-in-humans-ai.png","articleSection":["Art Community"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/development.brstdev.com\/cielcharlotte\/adjane-reports-first-clinical-validation-of-its-omv-vaccine-platform-inducing-mucosal-immunity-in-humans\/","url":"https:\/\/development.brstdev.com\/cielcharlotte\/adjane-reports-first-clinical-validation-of-its-omv-vaccine-platform-inducing-mucosal-immunity-in-humans\/","name":"AdJane Reports First Clinical Validation of its OMV Vaccine Platform Inducing Mucosal Immunity in Humans - Ciel Charlotte","isPartOf":{"@id":"https:\/\/development.brstdev.com\/cielcharlotte\/#website"},"primaryImageOfPage":{"@id":"https:\/\/development.brstdev.com\/cielcharlotte\/adjane-reports-first-clinical-validation-of-its-omv-vaccine-platform-inducing-mucosal-immunity-in-humans\/#primaryimage"},"image":{"@id":"https:\/\/development.brstdev.com\/cielcharlotte\/adjane-reports-first-clinical-validation-of-its-omv-vaccine-platform-inducing-mucosal-immunity-in-humans\/#primaryimage"},"thumbnailUrl":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-content\/uploads\/2026\/07\/adjane-reports-first-clinical-validation-of-its-omv-vaccine-platform-inducing-mucosal-immunity-in-humans-ai.png","datePublished":"2026-07-01T11:49:00+00:00","author":{"@id":"https:\/\/development.brstdev.com\/cielcharlotte\/#\/schema\/person\/4c5e38434c81d2ebb9c5787b29251450"},"breadcrumb":{"@id":"https:\/\/development.brstdev.com\/cielcharlotte\/adjane-reports-first-clinical-validation-of-its-omv-vaccine-platform-inducing-mucosal-immunity-in-humans\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/development.brstdev.com\/cielcharlotte\/adjane-reports-first-clinical-validation-of-its-omv-vaccine-platform-inducing-mucosal-immunity-in-humans\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/development.brstdev.com\/cielcharlotte\/adjane-reports-first-clinical-validation-of-its-omv-vaccine-platform-inducing-mucosal-immunity-in-humans\/#primaryimage","url":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-content\/uploads\/2026\/07\/adjane-reports-first-clinical-validation-of-its-omv-vaccine-platform-inducing-mucosal-immunity-in-humans-ai.png","contentUrl":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-content\/uploads\/2026\/07\/adjane-reports-first-clinical-validation-of-its-omv-vaccine-platform-inducing-mucosal-immunity-in-humans-ai.png","width":1536,"height":1024,"caption":"AdJane Reports First Clinical Validation of its OMV Vaccine Platform Inducing Mucosal Immunity in Humans"},{"@type":"BreadcrumbList","@id":"https:\/\/development.brstdev.com\/cielcharlotte\/adjane-reports-first-clinical-validation-of-its-omv-vaccine-platform-inducing-mucosal-immunity-in-humans\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/development.brstdev.com\/cielcharlotte\/"},{"@type":"ListItem","position":2,"name":"AdJane Reports First Clinical Validation of its OMV Vaccine Platform Inducing Mucosal Immunity in Humans"}]},{"@type":"WebSite","@id":"https:\/\/development.brstdev.com\/cielcharlotte\/#website","url":"https:\/\/development.brstdev.com\/cielcharlotte\/","name":"Ciel Charlotte","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/development.brstdev.com\/cielcharlotte\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/development.brstdev.com\/cielcharlotte\/#\/schema\/person\/4c5e38434c81d2ebb9c5787b29251450","name":"Ethan Parker","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-content\/uploads\/2026\/09\/ethan-parkar-96x96.jpeg","url":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-content\/uploads\/2026\/09\/ethan-parkar-96x96.jpeg","contentUrl":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-content\/uploads\/2026\/09\/ethan-parkar-96x96.jpeg","caption":"Ethan Parker"},"description":"Ethan Parker covers stories about community life, personal well-being, local initiatives, lifestyle trends, and the people working to create stronger communities. His writing looks for the human element behind larger developments, focusing on practical ideas and meaningful stories. Ethan brings an approachable perspective to subjects involving everyday life, community participation, creativity, and social connection.","url":"https:\/\/development.brstdev.com\/cielcharlotte\/author\/ethan-parker\/"}]}},"_links":{"self":[{"href":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-json\/wp\/v2\/posts\/3412","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-json\/wp\/v2\/comments?post=3412"}],"version-history":[{"count":1,"href":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-json\/wp\/v2\/posts\/3412\/revisions"}],"predecessor-version":[{"id":9102,"href":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-json\/wp\/v2\/posts\/3412\/revisions\/9102"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-json\/wp\/v2\/media\/3413"}],"wp:attachment":[{"href":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-json\/wp\/v2\/media?parent=3412"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-json\/wp\/v2\/categories?post=3412"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/development.brstdev.com\/cielcharlotte\/wp-json\/wp\/v2\/tags?post=3412"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}